Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI Listing Regulations, Fineotex Chemical has informed that Fineotex Biotex HealthGuard FZE (‘FZE Company’), a wholly owned subsidiary of the Company, has incorporated a new wholly-owned step-down subsidiary named Fineotex America Inc. (‘FAI’), in USA. The Company has received intimation today, 24th August, 2026 that the Certificate of Incorporation of FAI has been issued by the State of Delaware, USA. In this regard, Fineotex Chemical has informed that it enclosed the disclosure containing details as required under Regulation 30(6) read with clause (1) of Para A of Part A of Schedule III of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed as ‘Annexure - A’. The above information is also available on the website of the Company www.fineotex.com.
The above information is a part of company’s filings submitted to BSE.
